Blue-blocking lens performs like standard UV-absorbing model
July 1st 2003San Francisco-The AcrySof Natural IOL (Model SB30AL, Alcon), containing a covalently bonded, blue light-filtering chromophore (ImprUV), more closely mimics the light transmission spectrum of the precataractous adult human crystalline lens compared with standard UV-absorbing IOLs without any adverse effects on vision, said Paul H. Ernest, MD, at the American Society of Cata-ract and Refractive Surgery an-nual meeting.
Bimanual sleeveless phaco is safe, effective for hard nuclei
July 1st 2003San Francisco-Bimanual phacoemulsification can be performed safely and effectively with the Millennium Microsurgical System (Bausch & Lomb), said Rosa M. Braga-Mele, MD, at the American Society of Cataract and Refractive Surgery annual meeting.
Surgical planning key to restoring good vision in pediatric trauma cases
July 1st 2003San Francisco-IOL implantation in pediatric eyes with traumatic cataract offers the opportunity for a favorable visual outcome, but success in these cases depends on a properly timed procedure and diligent surgical care, said M. Edward Wilson, MD, at the American Society of Cataract and Refractive Surgery annual meeting.
Pseudoaccommodative IOL reduces aberration
July 1st 2003San Francisco-With its proprietary apodized diffractive technology, the AcrySof ReSTOR pseudoaccommodative IOL (Alcon) provides patients with excellent near and distance vision and only infrequently causes visual symptoms that are generally minimal and easily tolerated, said David Allen, MD, at the American Society of Cataract and Refractive Surgery annual meeting.
AAO squeezes "fresh ideas" into annual
July 1st 2003The focus of the American Academy of Ophthalmology's (AAO) annual meeting in Anaheim this November can be summed up in one word: fresh. As always, the annual meeting and subspecialty day meetings will provide the latest clinical updates and practical tools that attendees have come to expect, but with a fresh focus on their needs on everything from offerings to scheduling.
Dr. McDonnell to continue Wilmer's tradition of excellence
July 1st 2003Baltimore-Effective July 1, Peter J.McDonnell III, MD, leaves his post as chairman of the ophthalmology department at the University of California-Irvine to take the helm as director and William Holland Wilmer Professor of Ophthalmology at the Wilmer Eye Institute.
Redesigned 3-piece IOL has improved injectability
July 1st 2003San Francisco-The newly redesigned model CQ2003V Collamer 3-piece IOL (STAAR Surgical) provides patients with excellent visual results during the early postoperative period. The new IOL tolerates injection through a small cartridge compared with the previous design, according to Stephen Bylsma, MD, at the American Society of Cataract and Refractive Surgery (ASCRS) annual meeting.
Aniridic lens offers functional, cosmetic benefits
July 1st 2003San Francisco-Implantation of an aniridic colored IOL (Ophtec) in patients with traumatic aniridia is associated with improved photophobia and high patient satisfaction, reported Pascal Rozot, MD, at the American Society of Cataract and Refractive Surgery annual meeting.
Be proactive to avoid lawsuits from noncompliant patients
June 15th 2003San Francisco-Patients who repeatedly miss appointments or do not follow prescribed treatment plans can be walking litigation time bombs, according to attorney Paul Weber, JD, a risk manager at the Ophthalmic Mutual Insurance Co.
Ophthalmologists relying on optometrists in the office
June 15th 2003With daily operating costs rising, reimbursement rates declining, and concerns over soaring liability insurance prices, profitability is a hot topic for the modern ophthalmology practice. Some groups are finding an effective solution in the symbiosis between ophthalmology and optometry. By adding optometrists to their staffs, ophthalmologists are offering a more complete vision-care package to their patients and driving up profits in the process. The advantages, as seen by the doctors involved in these relationships, are many.
New device uses blade, cartridge, bar applanator to produce flap
June 15th 2003Reseda, CA-The Centurion SES Microkeratome, recently approved by the FDA, has features that differentiate it from conventional microkeratomes used for standard LASIK procedures: a combination blade/cartridge component, a bar applanator, and a resultant gutterless flap.
Zero-compression head helps reduce epithelial defect risk
June 15th 2003San Francisco-The new zero-compression head for the Hansatome microkeratome (Bausch & Lomb) represents an important safety advance for that instrument because it significantly reduces the risk of intraoperative epithelial defects compared with the standard head, said Thomas Kohnen, MD, at the American Society of Cataract and Refractive Surgery annual meeting.
Blade choice can affect flap thickness but quality is constant
June 15th 2003San Francisco-Refractive surgeons using the MK-2000 (Nidek) microkeratome can expect to achieve high-quality flaps whether using the manufacturer's own or another's blade, but they need to recognize that blades from different manufacturers and even from different lots of the same manufacturer may produce flaps that can vary dramatically in thickness, said Robert T. Lin, MD, at the American Society of Cataract and Refractive Surgery annual meeting.
Disposable microkeratome makes flap creation simple, safe
June 15th 2003San Francisco-The CB Single Use microkeratome (Moria, Antony, France) is a reliable instrument for flap creation, offering advantages in safety and ease of use, said Karl B. Stonecipher, MD, at the American Society of Cataract and Refractive Surgery annual meeting.
Opacity no barrier to lamellar keratectomy with FS laser
June 15th 2003San Francisco-The femtosecond laser (IntraLase FS, IntraLase Corp.) holds promise as a useful tool for performing keratectomy in eyes undergoing lamellar keratoplasty procedures, said Melvin A. Sarayba, MD,at the American Society of Cataract and Refractive Surgery annual meeting.
Pushing the envelope with excessively thin flaps can be hazardous
June 15th 2003San Francisco-LASIK surgeons seeking to create thin flaps in order to maximize ablation depth while maintaining a 250-?m stromal bed would be prudent to set 120 to 130 ?m as their lower limit for intended flap thickness, said Lee T. Nordan, MD, at the American Society for Cataract and Refractive Surgery annual meeting.
Injector system has environmentally controlled cartridge
June 15th 2003Monrovia, CA-STAAR Surgical has introduced an environmentally controlled cartridge for its injector systems that appears to maintain high lubricity and improve performance during IOL implantation, accord-ing to several physiciansfamiliar with the new system.
How to handle a small pupil in combined surgery
June 15th 2003The pupil that dilates poorly is frequently associated with both glaucoma and complications during combined surgery. With newer endolenticular techniques, especially with nucleofractis procedures and chop techniques, pupils do not need to be as large as previously required.1-4 However, there still are numerous instances in which the pupil is inadequate to allow the surgeon to proceed, and some form of manipulation or surgery is required.
Corneal topography, wavefront data essential for customized ablations
June 15th 2003San Francisco-Corneal topography and wavefront data are key to assessing the internal aberrations of the eye accurately and are essential for surgeons to perform customized ablations accurately, said Stephen D. Klyce, PhD, who spoke during the Innovator's Session at the American Society of Cataract and Refractive Surgery annual meeting.
Refractive surgery reaches new heights through innovation
June 15th 2003San Francisco-Refractive surgery continues to evolve as researchers strive to achieve better quality of vision for patients, said Ioannis G. Pallikaris, MD, PhD, the first ophthalmologist to deliver the Charles D. Kelman Innovator's Lecture at the American Society of Cataract and Refractive Surgery annual meeting.
Sympathetic ophthalmia not fully understood 100 years later
June 15th 2003Editor's Note: What has 100 years of history done for ophthalmic knowledge? In many areas-cataract surgery for example-a revolution has occurred and great strides have been made. In others, surprisingly, very little has advanced.
Bausch & Lomb to delay regulatory filing
June 15th 2003Rochester, NY-Bausch & Lomb will delay the regulatory filing for the intravitreal fluocinolone acetonide implant (Retisert), a treatment for diabetic macular edema (DME), for up to 3 years while the FDA reviews 12-month safety data of additional eyes treated with implants.